19:02 , Dec 7, 2018 |  BC Week In Review  |  Financial News

Gates leads Kallyope's $21M B round expansion

Bill Gates has joined an existing investor syndicate to lead a $21 million expansion of a series B round for Kallyope Inc. (New York, N.Y.). Kallyope has now raised $87 million in the round and...
19:45 , Dec 5, 2018 |  BC Extra  |  Financial News

Gates leads Kallyope's $21M B round expansion

Bill Gates has joined an existing investor syndicate to lead a $21 million expansion of a series B round for Kallyope Inc. (New York, N.Y.). Kallyope has now raised $87 million in the round and...
18:29 , Nov 30, 2018 |  BC Week In Review  |  Financial News

Neurodegeneration play Rheostat raises $23M series A

Rheostat Therapeutics (Cambridge, Mass.) raised $23 million in a series A round to bring its first programs in neurodegenerative disease to IND. The round was co-led by MRL Ventures Fund and AbbVie Ventures, with participation...
00:06 , Nov 27, 2018 |  BC Extra  |  Financial News

Neurodegeneration play Rheostat raises $23M series A

Rheostat Therapeutics (Cambridge, Mass.) raised $23 million in a series A round to bring its first programs in neurodegenerative disease to IND. The round was co-led by MRL Ventures Fund and AbbVie Ventures, with participation...
15:56 , Nov 16, 2018 |  BC Week In Review  |  Financial News

M Ventures leads $30M series A for RNA start-up Ribometrix

RNA company Ribometrix Inc. (Durham, N.C.) raised $30 million in a series A round led by M Ventures on Nov. 13. Fellow new investors Amgen Ventures, Pappas Capital and Illumina Ventures also participated, as did...
15:55 , Nov 16, 2018 |  BC Week In Review  |  Financial News

Hillhouse, Quan lead $93M series B for immuno-oncology play NextCure

NextCure Inc. (Beltsville, Md.) raised $93 million on Nov. 13 in a series B round led by new investors Hillhouse Capital Management and Quan Capital to fund development of its two lead immuno-oncology candidates. PD-1...
11:35 , Nov 13, 2018 |  BC Extra  |  Financial News

M Ventures leads $30M series A for RNA start-up Ribometrix

RNA company Ribometrix Inc. (Durham, N.C.) raised $30 million in a series A round led by M Ventures. Fellow new investors Amgen Ventures, Pappas Capital and Illumina Ventures also participated, as did existing investors SV...
11:33 , Nov 13, 2018 |  BC Extra  |  Financial News

Hillhouse, Quan lead $93M series B for immuno-oncology play NextCure

NextCure Inc. (Beltsville, Md.) raised $93 million in a series B round led by new investors Hillhouse Capital Management and Quan Capital to fund development of its two lead immuno-oncology candidates. PD-1 pioneer Lieping Chen...
11:33 , Nov 13, 2018 |  BioCentury  |  Finance

Playing in RNA

M Ventures, the strategic venture arm of Merck KGaA (Xetra:MRK), is adding another RNA company to its portfolio by leading a $30 million series A round for Ribometrix Inc. Fellow new investors Amgen Ventures, Pappas...
19:08 , Oct 26, 2018 |  BC Week In Review  |  Financial News

Stoke prepares for IND, IPO with $90M series B

Stoke Therapeutics Inc. (Bedford, Mass.) is eyeing an IPO next half after raising $90 million in a series B round on Oct. 23 from a slew of new investors. The company's Targeted Augmentation of Nuclear...